832 results on '"Testani, Jeffrey M."'
Search Results
2. Effects of Dapagliflozin on Body Composition and Its Relation to Hemodynamics in Heart Failure With Preserved Ejection Fraction
3. A randomized clinical trial assessing the effect of automated medication-targeted alerts on acute kidney injury outcomes
4. Renin-Angiotensin-Aldosterone System Activation and Diuretic Response in Ambulatory Patients With Heart Failure
5. Contemporary Decongestion Strategies in Patients Hospitalized for Heart Failure: A National Community-Based Cohort Study
6. Association of Urine Galectin-3 With Cardiorenal Outcomes in Patients With Heart Failure
7. Peak Tricuspid Regurgitation Jet Velocity and Kidney Outcomes in Patients With Heart Failure With Preserved Ejection Fraction
8. Sodium Zirconium Cyclosilicate in HFrEF and Hyperkalemia: REALIZE-K Design and Baseline Characteristics
9. Empagliflozin in Heart Failure: Regional Nephron Sodium Handling Effects
10. Randomized controlled trial of urinE chemiStry guided aCute heArt faiLure treATmEnt (ESCALATE): Rationale and design
11. Effect of Sotagliflozin on Early Mortality and Heart Failure-Related Events: A Post Hoc Analysis of SOLOIST-WHF
12. Abstract 17773: Novel Partition Scores Identify Pathways Implicated in Clonal Hematopoiesis of Indeterminate Potential (CHIP) Mediated Heart Failure
13. Abstract 11968: Association of Invasive Measures of Congestion With Short- and Long-Term Kidney Function Outcomes Among Patients With Acute Decompensated Heart Failure
14. Updates in Cardiorenal Syndrome
15. The importance of forward flow and venous congestion in diuretic response in acute heart failure: Insights from the ESCAPE trial
16. Changes in the Inferior Vena Cava Are More Sensitive Than Venous Pressure During Fluid Removal: A Proof-of-Concept Study
17. Effect on Survival of Concurrent Hemoconcentration and Increase in Creatinine During Treatment of Acute Decompensated Heart Failure
18. Risk stratification of patients listed for heart transplantation while supported with extracorporeal membrane oxygenation
19. Critical Analysis of the Effects of SGLT2 Inhibitors on Renal Tubular Sodium, Water and Chloride Homeostasis and Their Role in Influencing Heart Failure Outcomes
20. Volenrelaxin (LY3540378) increases Renal Plasma Flow: A Randomized Phase 1 Trial
21. Sodium zirconium cyclosilicate in patients with HFrEF and hyperkalemia: REALIZE-K rationale, design, and baseline characteristics
22. Serial direct sodium removal in patients with heart failure and diuretic resistance
23. The salt paradox in heart failure
24. Rates of In-Hospital Decongestion and Association with Mortality and Cardiovascular Outcomes Among Patients Admitted for Acute Heart Failure
25. Improvement in Renal Function During the Treatment of Acute Decompensated Heart Failure: Relationship With Markers of Renal Tubular Injury and Prognostic Importance
26. Renal Hemodynamics and Renin-Angiotensin-Aldosterone System Profiles in Patients With Heart Failure
27. Multinephron Segment Diuretic Therapy to Overcome Diuretic Resistance in Acute Heart Failure: A Single-Center Experience
28. Early diuretic strategies and the association with In-hospital and Post-discharge outcomes in acute heart failure
29. Loop Diuretic Resistance in a Patient with Acute Heart Failure
30. Kidney and heart failure events are bidirectionally associated in patients with type 2 diabetes and cardiovascular disease
31. Empagliflozin in Heart Failure: Regional Nephron Sodium Handling Effects
32. Abstract 15681: Impact of Dietary Sodium Restriction on Heart Failure Outcomes: A Systematic Review and Meta-Analysis
33. Pragmatic Design of Randomized Clinical Trials for Heart Failure: Rationale and Design of the TRANSFORM-HF Trial
34. Natriuretic Equation to Predict Loop Diuretic Response in Patients With Heart Failure
35. Differential Impact of Class I and Class II Panel Reactive Antibodies on Post-Heart Transplant Outcomes
36. Cystatin C and Muscle Mass in Patients With Heart Failure
37. Extracorporeal Ultrafiltration for Fluid Overload in Heart Failure Current Status and Prospects for Further Research
38. “Dip” in eGFR: Stay the Course With SGLT-2 Inhibition
39. Association of Volume Overload With Kidney Function Outcomes Among Patients With Heart Failure With Reduced Ejection Fraction
40. COVID-19−Associated Acute Kidney Injury and Longitudinal Kidney Outcomes.
41. Kidney and heart failure events are bidirectionally associated in patients with type 2 diabetes and cardiovascular disease.
42. Acute Kidney Function Declines in the Context of Decongestion in Acute Decompensated Heart Failure
43. Effect of Loop Diuretics on the Fractional Excretion of Urea in Decompensated Heart Failure
44. Real World Use of Hypertonic Saline in Refractory Acute Decompensated Heart Failure: A U.S. Center’s Experience
45. Diuretic Strategies for Loop Diuretic Resistance in Acute Heart Failure: The 3T Trial
46. Adverse Renal Response to Decongestion in the Obese Phenotype of Heart Failure With Preserved Ejection Fraction
47. Loop diuretic resistance complicating acute heart failure
48. Natriuretic Response Is Highly Variable and Associated With 6-Month Survival: Insights From the ROSE-AHF Trial
49. Integration of implantable device therapy in patients with heart failure. A clinical consensus statement from the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC).
50. Outcomes Associated with Sodium-Glucose Cotransporter-2 Inhibitor Use in Acute Heart Failure Hospitalizations Complicated by Acute Kidney Injury
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.